Skip to main content

Table 1 Clinical characteristics of 173 AML patients according to VIM expression Z-score ≥ 1

From: Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia

Characteristic Z-score (< 1) (n = 145) Z-score (≥ 1) (n = 28) p value
Age, median (years) 57 63.5 0.048
 Young (< 60 years) 81 (55.9%) 10 (64.3%) 0.063
 Old (> 60 years) 64 (44.1%) 18 (35.7%)  
Sex
 Female (n, %) 68 (46.9%) 13 (46.4%) > 0.999
 Male (n, %) 77 (53.1%) 15 (53.6%)  
FAB
 M0 (n, %) 15 (10.3%) 1 (3.57%) 0.476
 M1 (n, %) 39 (26.9%) 5 (17.9%) 0.353
 M2 (n, %) 34 (23.5%) 4 (14.3%) 0.329
 M3 (n, %) 11 (7.59%) 5 (17.9%) 0.146
 M4 (n, %) 27 (18.6%) 7 (25.00%) 0.446
 M5 (n, %) 12 (8.28%) 6 (21.4%) 0.083
 M6 (n, %) 2 (1.38%) 0 (0.00%) > 0.999
 M7 (n, %) 3 (2.07%) 0 (0.00%) > 0.999
WB count, median 12.6 69.2 < 0.001
 ln (WB count), mean 2.446 3.749 < 0.001
% BM blast, median 71 82.5 0.017
% PB blast, median 34 44.5 0.253
Risk status
 Poor (n, %) 42 (29.0%) 3 (10.7%) 0.057
 Intermediate (n, %) 73 (50.3%) 19 (67.9%) 0.091
 Good (n, %) 28 (19.3%) 5 (17.9%) > 0.999
Cytogenetic status
 Normal (n, %) 60 (41.4%) 20 (71.4%) 0.003
 Abnormal (n, %) 83 (57.2%) 7 (25.0%)  
Transplant status
 No (n, %) 78 (53.8%) 22 (78.6%) 0.021
 Yes (n, %) 67 (46.2%) 6 (21.4%)